Search

Displaying results 7061 - 7070 of 10000 in total
  1. Drug

    Rebaudioside A

    go.drugbank.com/drugs/DB15136
    Investigational

    Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).

    Synonyms: Rebaudioside A
  2. Drug

    ASF-1075

    go.drugbank.com/drugs/DB05727
    Experimental

  3. Drug

    EMD-1201081

    go.drugbank.com/drugs/DB06181
    Investigational

    Categories: Toll-Like Receptor 9, agonists
  4. Drug

    Repifermin

    go.drugbank.com/drugs/DB06434
    Experimental

  5. Drug

    Edifoligide

    go.drugbank.com/drugs/DB06556
    Investigational

  6. Drug

    PRX-08066

    go.drugbank.com/drugs/DB05607
    Investigational

    Synonyms: 5-((4-(6-CHLOROTHIENO(2,3-D)PYRIMIDINE-4-YLAMINO)PIPERIDIN-1-YL)METHYL)-2-FLUOROBENZONITRILE MONOFUMURATE, 5-((4-(6-chlorothieno[2,3-d]pyrimidine-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile monofumurateCategories: Heterocyclic Compounds, 1-Ring, Serotonin 5-HT2 Receptor Antagonists
  7. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

    Categories: Heterocyclic Compounds, 2-Ring
  8. Drug

    Chloropyramine

    go.drugbank.com/drugs/DB08800
    Investigational

    Chlorpyramine is a first generation antihistamine used in Eastern European countries to treat bronchial asthma as well as allergice rhinitis, allergic conjunctivitis, and other allergic reactions. … It is also indicated for Quincke's edema, allergic reactions to insect bites, food and drug allergies, and anaphylactic shock.

  9. Drug

    Eribulin

    go.drugbank.com/drugs/DB08871
    ApprovedInvestigational

    Eribulin is also being investigated for use in the treatment of advanced solid tumors [A7439]. … Eribulin is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic

    Categories: Heterocyclic Compounds, 1-RingProducts: ERIBULINA EG
  10. Drug

    Melanoma antigen recognized by T-cells 1

    go.drugbank.com/drugs/DB15081
    Investigational

    Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

    Synonyms: Melanoma antigen recognized by T-cells 1